167 related articles for article (PubMed ID: 19732414)
41. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
42. Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice.
Lee YC; Asa SL; Drucker DJ
J Biol Chem; 1992 May; 267(15):10705-8. PubMed ID: 1587847
[TBL] [Abstract][Full Text] [Related]
43. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
44. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
45. Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.
Steiner J; Davis J; McClellan J; Enos R; Carson J; Fayad R; Nagarkatti M; Nagarkatti P; Altomare D; Creek K; Murphy E
Cancer Biol Ther; 2014; 15(11):1456-67. PubMed ID: 25482952
[TBL] [Abstract][Full Text] [Related]
46. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions.
Burrai GP; Mohammed SI; Miller MA; Marras V; Pirino S; Addis MF; Uzzau S; Antuofermo E
BMC Cancer; 2010 Apr; 10():156. PubMed ID: 20412586
[TBL] [Abstract][Full Text] [Related]
47. Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model.
Holzer RG; MacDougall C; Cortright G; Atwood K; Green JE; Jorcyk CL
Breast Cancer Res Treat; 2003 Jan; 77(1):65-76. PubMed ID: 12602905
[TBL] [Abstract][Full Text] [Related]
48. Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.
Shibata MA; Jorcyk CL; Devor DE; Yoshidome K; Rulong S; Resau J; Roche N; Roberts AB; Ward JM; Green JE
Carcinogenesis; 1998 Jan; 19(1):195-205. PubMed ID: 9472712
[TBL] [Abstract][Full Text] [Related]
49. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
50. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
51. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
52. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
Guy CT; Cardiff RD; Muller WJ
Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
[TBL] [Abstract][Full Text] [Related]
53. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling.
Zhang X; Mehta RG; Lantvit DD; Coschigano KT; Kopchick JJ; Green JE; Hedayat S; Christov KT; Ray VH; Unterman TG; Swanson SM
Carcinogenesis; 2007 Jan; 28(1):143-50. PubMed ID: 16916863
[TBL] [Abstract][Full Text] [Related]
55. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
56. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
[TBL] [Abstract][Full Text] [Related]
57. MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer.
Markiewicz E; Fan X; Mustafi D; Zamora M; Conzen SD; Karczmar GS
Magn Reson Imaging; 2017 Jul; 40():48-52. PubMed ID: 28366759
[TBL] [Abstract][Full Text] [Related]
58. Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential.
Tsubura A; Yoshizawa K; Uehara N; Yuri T; Matsuoka Y
Med Mol Morphol; 2007 Mar; 40(1):9-17. PubMed ID: 17384984
[TBL] [Abstract][Full Text] [Related]
59. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
[TBL] [Abstract][Full Text] [Related]
60. Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice.
Mastini C; Becker PD; Iezzi M; Curcio C; Musiani P; Forni G; Cavallo F; Guzmán CA
Curr Cancer Drug Targets; 2008 May; 8(3):230-42. PubMed ID: 18473736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
